ARDX vs EXC · rev $215.3M vs P/E 17, rev $24.26B
Ardelyx Inc (ARDX) versus Exelon Corporation (EXC) — a side-by-side from cached financials, not a winner call.
Ardelyx Inc (ARDX) is a biotechnology company listed on US.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Latest reported ARDX revenue for 2026-06-30 was $215.3M. Net income was -$54.3M. ARDX currently screens at market cap $1.37B.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
ARDX currently screens at market cap $1.37B. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Not investment advice. Open the ARDX and EXC stock pages for the full models.
Not investment advice.